+ All Categories
Home > Documents > Print 1 Farmokologi

Print 1 Farmokologi

Date post: 04-Apr-2018
Category:
Upload: shindrummer
View: 223 times
Download: 0 times
Share this document with a friend

of 38

Transcript
  • 7/30/2019 Print 1 Farmokologi

    1/38

    Pharmacokinetics

  • 7/30/2019 Print 1 Farmokologi

    2/38

    Site of

    ActionDosage Effects

    Plasma

    Concen.

    Pharmacokinetics Pharmacodynamics

  • 7/30/2019 Print 1 Farmokologi

    3/38

    Systemic Availability

  • 7/30/2019 Print 1 Farmokologi

    4/38

    A discipline that concerns the study and

    characterization of the time course of drug

    Absorption

    Distribution

    Metabolism

    Excretion

  • 7/30/2019 Print 1 Farmokologi

    5/38

    Bound Free Free Bound

    LOCUS OF ACTION

    RECEPTORS

    TISSUE

    RESERVOIRS

    SYSTEMICCIRCULATION

    Free Drug

    Bound Drug

    ABSORPTION EXCRETION

    BIOTRANSFORMATION

  • 7/30/2019 Print 1 Farmokologi

    6/38

    Passage of drugs across membranes

    Structure of the plasma membrane

  • 7/30/2019 Print 1 Farmokologi

    7/38

    Mechanisms of transport

    Passive diffusion: passage of drugs through the

    lipid surface (major mechanism of drug

    absorption)

    Lipid-soluble drugs

    Small water-soluble drugs

    Noncharged form of weak electrolytes

  • 7/30/2019 Print 1 Farmokologi

    8/38

    Membrane permeability versus lipid (olive

    oil):water partition coefficientsolubility

    The greater the partition coefficient, the

    higher the lipid-solubility of the drug, andthe greater its diffusion across membranes.

  • 7/30/2019 Print 1 Farmokologi

    9/38

    Weak electrolytes and membrane permeability

    Most drugs are small (MW < 1000)weak

    electrolytes (acids/bases). This influences passive

    diffusion since cell membranes are hydrophobiclipid bilayers that are much more permeable to thenon-ionized forms of drugs.

    The fraction of drug that is non-ionized dependson its chemical nature, its pKa, and the localbiophase pH...

  • 7/30/2019 Print 1 Farmokologi

    10/38

    pH - pKa = logbase

    acid

    Henderson-Hasselbach equation

    For an acidic drug: acid = HA; base = A-

    For a basic drug: acid = BH+; base = B

  • 7/30/2019 Print 1 Farmokologi

    11/38

    Acids are increasingly ionized withincreasing pH (basic environment),

    whereas

    Bases are increasingly ionized with

    decreasing pH (acidic environment).

  • 7/30/2019 Print 1 Farmokologi

    12/38

    Filtration: bulk flow of water-soluble drugs

    through pores (glomerular, capillary)

    Facilitated diffusion: carrier-mediated, ATPnot required (e.g., glucose)

    Active transport: carrier-mediated, ATPrequired (e.g., Na+, K+, Ca++)

    Endocytosis and exocytosis: (e.g., forvery large compounds)

  • 7/30/2019 Print 1 Farmokologi

    13/38

    Drug Absorption & Route of administration

    Absorption describes the rate and extent at

    which a drug leaves its site of administration.

    Bioavailability (F) is the extent to which a drug

    reaches its site of action, or to a biological fluid

    (such as plasma) from which the drug has accessto its site of action.

  • 7/30/2019 Print 1 Farmokologi

    14/38

    AUC

    injected I.v.

    AUC

    oral

    time

    plas

    maconcentrationofdru

    g

    Bioavailability =AUC oral

    AUC injected i.v.

    X 100

    AUC = area under the curve

  • 7/30/2019 Print 1 Farmokologi

    15/38

    Route of administration

    ORAL INGESTION , governed by:

    surface area for absorption, blood flow, physical

    state of drug, concentration.

    occurs via passive process.

    In theory: weak acids optimally absorbed in

    stomach, weak bases in intestine.

    In reality: the overall rate of absorption of drugs is

    always greater in the intestine (surface area, organ

    function).

  • 7/30/2019 Print 1 Farmokologi

    16/38

    Unique characteristics of the oral route

    Influences of gastric emptying (accelerates gastricemptying increase the rate of absorption)

    Small intestine usually most important because of

    large surface area (folds of Kerckring, villi, microvilli)

    The motility of the small intestine

    Drug inactivation important for oral route

    stomach (acid), small intestine (ester/otherenzyme), distal small intestine/colon (gut bact)

  • 7/30/2019 Print 1 Farmokologi

    17/38

    Ingestion of a solid dosage form with a glass of

    cold water, fasting, lying on the right side,hyperthyroidism accelerate gastric emptying

    Ingestion with a fatty meal, acidic drink, or with

    another drug with anticholinergic properties, lyingon the left side, hypothyroidism, sympathetic

    output (as in stress) retard gastric emptying.

  • 7/30/2019 Print 1 Farmokologi

    18/38

    Clinical advantages

    Safest route Cheapest route

    Best patient acceptance

    Disadvantages

    Delayed effect

    Patient cooperation required

    Unique problems with GI toxicity

  • 7/30/2019 Print 1 Farmokologi

    19/38

    INJECTION

    subcutaneous, intramuscular absorbed by

    diffusion and affected by blood flow

    intravenous, intraarterial injection avoidsabsorption

    MUCOUS MEMBRANE

    sublingual, buccal, nasal, vaginal or rectalmucosa: passive diffusion

  • 7/30/2019 Print 1 Farmokologi

    20/38

    LUNG

    Inhalation: passive diffusion, rapid absorption,dependent on particle size (6 m cutoff)

    SKIN

    Transdermal

  • 7/30/2019 Print 1 Farmokologi

    21/38

    Important Properties Affecting

    Drug Absorption

    Chemical properties

    acid or base

    degree of ionizationpolarity

    molecular weight

    lipid solubility or...

    partition coefficient

    Physiologic variables

    gastric motility

    pH at the absorption sitearea of absorbing surface

    blood flow

    pre absorptive hydrolysis

    ingestion w/wo food

  • 7/30/2019 Print 1 Farmokologi

    22/38

    Extent of metabolism occurring before drug

    enters systemic circulation

    Main site: Liver

    Decrease in drug efficacy (orally) can beovercome by using a greater dose

    Example: Propranolol (5 mg vs. 100 mg)

    Extensive metabolism may render oral admin.impossible

    Example: Lidocaine

    First-Pass Metabolism

  • 7/30/2019 Print 1 Farmokologi

    23/38

    The fraction of drug eliminated from portal blood

    during absorption hepatic extraction ratio(ERH)

    ERH = ClH/ QH

    Bioavaibilty (F) F = 1- ERH

  • 7/30/2019 Print 1 Farmokologi

    24/38

    Distribution

    Only that fraction of drug which is non-protein-

    bound can bind to cellular receptors and pass

    across tissue membranes, thus being distributed to

    other body tissues, metabolized, and excreted.

    The actual pattern of drug distribution reflects

    various physiological factors and physicochemicalproperties of the drug.

  • 7/30/2019 Print 1 Farmokologi

    25/38

    Plasma protein

    albumin- binds many acidic drugs

    a1-acid glycoprotein for basic drugs

    The fraction of total drug in plasma that isbound is determined by its concentration, itsbinding affinity, and the number of bindingsites.

  • 7/30/2019 Print 1 Farmokologi

    26/38

    Phases of Distribution

    first phase

    reflects cardiac output and regional blood

    flow. Thus, heart, liver, kidney & brainreceive most of the drug during the firstfew minutes after absorption.

    next phase

    delivery to muscle, most viscera, skin andadipose is slower, and involves a far largerfraction of the body mass.

  • 7/30/2019 Print 1 Farmokologi

    27/38

    Drugs Binding Primarily to

    Albuminbarbiturate probenecid

    benzodiazepines streptomycin

    bilirubin sulfonamidesdigotoxin tetracycline

    fatty acids tolbutamide

    penicillins valproic acid

    phenytoin warfarin

    phenylbutazone

  • 7/30/2019 Print 1 Farmokologi

    28/38

    Drugs Binding Primarily to

    a1-Acid Glycoprotein

    alprenolol lidocaine

    bupivicaine methadonedesmethylperazine prazosin

    dipyridamole propranolol

    disopyramide quinidine

    etidocaine verapamilimipramine

  • 7/30/2019 Print 1 Farmokologi

    29/38

    Drugs Binding Primarily to

    Lipoproteins

    amitriptyline

    nortriptyline

  • 7/30/2019 Print 1 Farmokologi

    30/38

    Body compartments where a drug canaccumulate are reservoirs. They havedynamic effects on drug availability.

    GIT

    plasma proteins as reservoirs (bind drug)

    cellular reservoirs

    Adipose (lipophilic drugs) Bone (crystal lattice)

    Transcellular (ion trapping)

    Drug Reservoirs

  • 7/30/2019 Print 1 Farmokologi

    31/38

  • 7/30/2019 Print 1 Farmokologi

    32/38

    Bone Reservoir

    Tetracycline antibiotics (and other divalentmetal ion-chelating agents) and heavy metalsmay accumulate in bone. They are adsorbed

    onto the bone-crystal surface and eventuallybecome incorporated into the crystal lattice.

    Bone then can become a reservoir for slow

    release of toxic agents (e.g., lead, radium)into the blood.

  • 7/30/2019 Print 1 Farmokologi

    33/38

    Adipose Reservoir

    Many lipid-soluble drugs are stored in fat.

    In obesity, fat content may be as high as

    50%, and in starvation it may still be only aslow as 10% of body weight.

    70% of a thiopental dose may be found in

    fat 3 hr after administration.

  • 7/30/2019 Print 1 Farmokologi

    34/38

    GI Tract as Reservoir

    Weak bases are passively concentrated in thestomach from the blood because of the largepH differential.

    Some drugs are excreted in the bile in activeform or as a conjugate that can be hydrolyzedin the intestine and reabsorbed.

    In these cases, and when orally administereddrugs are slowly absorbed, the GI tract servesas a reservoir.

  • 7/30/2019 Print 1 Farmokologi

    35/38

    Redistribution

    Termination of drug action is normally by

    biotransformation/excretion, but may also

    occur as a result of redistribution betweenvarious compartments.

    Particularly true for lipid-soluble drugs that

    affect brain and heart.

  • 7/30/2019 Print 1 Farmokologi

    36/38

    Redistribution of thiopental after intravenousinjection

    Thio

    pentalconcentrat

    ion

    (as

    percentofinitiald

    ose)

    100

    50

    0

    minutes

    1 10 100 1000

    blood

    brainmuscle adipose

  • 7/30/2019 Print 1 Farmokologi

    37/38

    Central nervous system: permeable to lipid-

    soluble drugs only; limited permeability to water-

    soluble drugs when inflamed

    Placental transfer: limited by blood flow, not by a"barrier"

  • 7/30/2019 Print 1 Farmokologi

    38/38

    Plasma protein binding

    Specific receptor sites in tissues

    Regional blood flow

    Lipid solubility

    Active transport

    Disease

    Effects of other drugs

    Tissue Distribution - Factors


Recommended